Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
in the sixth column, expiration of approval, of row 145, captan, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 146, folpet, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 147, formetanate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 148, methiocarb, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 149, dimethoate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 150, dimethomorph, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 151, glufosinate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 152, metribuzin, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 153, phosmet, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 154, propamocarb, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 155, ethoprophos, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 156, pirimiphos-methyl, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 157, fipronil, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
in the sixth column, expiration of approval, of row 158, beflubutamid, the date of ‘30 November 2017’ is replaced by ‘31 July 2018’.